Skip to content
TriangleGet started
← Survival collections

ARCHIVED POPULATION DATA

Ovary

Archived November 2024 SEER release. This is relative survival from diagnosis for the published population, not an individual prediction or a treatment-effect estimate.

Relative survival across follow-up

0%25%50%75%100%0246810Years since diagnosis
Exact archived source values · CI = confidence interval
YearRelative survival (%)95% CI lower95% CI upperStandard errorCases
0100Not publishedNot publishedNot published160061
177.258277.044577.47020.1086160061
267.091866.848467.33390.1238160061
359.01458.754659.27230.1321160061
452.890752.622453.15820.1367160061
548.366848.092748.64020.1397160061
645.077844.799245.3560.142160061
742.673442.390442.9560.1443160061
840.896940.609241.18430.1467160061
939.50739.214139.79980.1494160061
1038.450738.151838.74940.1525160061
Permanent reference to this archived population →
Source definitions, footnotes and provenance
age and race caveat
Published age/race categories can overlap. They are selectable strata, not partitions to add together.
cohort count definition
Source Number of Cases, repeated by follow-up row; not people remaining at risk.
content sha256
3961eb49f11b5982831042b2ecad680ef5a8dd3cf2c2e5500e5fe57fdcb4cadd
dimensions
Age at Diagnosis
  1. Ages 15-39
  2. Ages 40-64
  3. Ages 50-64
  4. Ages 65+
  5. Ages 65-74
  6. Ages 75+
  7. Ages < 15
  8. Ages < 20
  9. Ages < 50
  10. All Ages
Race/Ethnicity
  1. All Races / Ethnicities
  2. Black (includes Hispanic)
  3. Hispanic (any race)
  4. Non-Hispanic American Indian / Alaska Native
  5. Non-Hispanic Asian / Pacific Islander
  6. Non-Hispanic Black
  7. Non-Hispanic White
  8. White (includes Hispanic)
Sex
  1. Female
Stage at Diagnosis
  1. All Stages
  2. Distant
  3. Localized
  4. Regional
  5. Unstaged
Years of Diagnosis
  1. 2000-2021
id
ovary
immutable id
seer-group:ovary@3961eb49f11b5982831042b2ecad680ef5a8dd3cf2c2e5500e5fe57fdcb4cadd
method
Relative survival calculated using monthly intervals; table publishes annual landmarks from diagnosis through year ten.
missing value definition
Source dash (-) does not differentiate suppression, unavailable data, or other missingness. No suppression reason is inferred.
normalized source
file
normalized/followup/ovary.json.gz
sha256
4b5153314804813845cb8aa8145b3cc12c10d307b9a47bda6787dbcd5c8c550e
period interpretation
The displayed diagnosis period is the source table label. Exact case-eligible years are not inferred from it.
registry
SEER 21 (excluding Illinois)
sheet
Ovary
site
Ovary
source
bytes
45275886
file
raw/Survival by Survival Time, November 2024.xlsx
retrieved at
2026-09-09T23:23:39.141323+00:00
sha256
4300662c48518fc384f68c039c8bbcd2a072e603576b36d327e6b17f80771e34
title
Survival by Survival Time
source footnotes
  1. row
    4408
    values
    1. Footnotes
  2. row
    4409
    values
    1. Data Source:
  3. row
    4410
    values
    1. -SEER Incidence Data, November 2024 Submission (1975-2022), SEER 21 registries [https://seer.cancer.gov/registries/terms.html] (excluding Illinois).
  4. row
    4411
    values
    1. -Expected Survival Life Tables [https://seer.cancer.gov/expsurvival/] by Socio-Economic Standards.
  5. row
    4412
    values
    1. Methodology:
  6. row
    4413
    values
    1. -The relative survival rates are calculated using monthly intervals.
  7. row
    4414
    values
    1. Race/Ethnicity Coding:
  8. row
    4415
    values
    1. -For more details on SEER race/ethnicity groupings, please see Race and Hispanic Ethnicity Changes [https://seer.cancer.gov/seerstat/variables/seer/race_ethnicity/].
  9. row
    4416
    values
    1. -Incidence data for Hispanics and Non-Hispanics are based on the NAACCR Hispanic Latino Identification Algorithm (NHIA).
  10. row
    4417
    values
    1. -Rates for American Indians/Alaska Natives only include cases that are in a Purchased/Referred Care Delivery Area (PRCDA).
  11. row
    4418
    values
    1. Cancer Site Coding:
  12. row
    4419
    values
    1. -See SEER*Explorer Cancer Site Definitions [https://seer.cancer.gov/statistics-network/explorer/cancer-sites.html] for details about the cancer site coding used for SEER Incidence data.
source header rows
    1. SEER Explorer Data Archive, November 2024 SEER Submission (April 2025 Release)
    1. Ovary
    1. SEER Relative Survival Rates by Time Since Diagnosis
    source missing marker
    -
    stage coding footnotes
    1. row
      4420
      values
      1. -Stage at diagnosis is calculated using the Combined Summary Stage (2004+) recode, created from SEER Combined Summary Stage 2000 (2004-2017) & Derived Summary Stage 2018 (2018+). For more information, see the SEER documentation[https://seer.cancer.gov/seerstat/variables/seer/lrd-stage].
    stage period caveat
    Combined Summary Stage (2004+) uses coding starting in 2004; the 2000-2021 label must not be read as full stage-specific coverage from 2000.
    stage system
    Combined Summary Stage (2004+)

    Preserved source evidence · Independent clinical review pending · Not medical advice